Kronos Bio, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
KRON on Nasdaq
Industry
Pharmaceutical Preparations
Location
1300 S. El Camino Real, Suite 400, San Mateo, California

Insiders trading volume in the past year

Kronos Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Norbert W. Bischofberger PRESIDENT & CEO, Director $13.5M +$5.32M +65.5% Jun 27, 2024
Barbara Kosacz COO & General Counsel $1.1M -$12.6K -1.14% Jan 4, 2024
Yasir B. Al-Wakeel Chief Financial Officer $410K Jul 6, 2023
Jorge DiMartino Chief Medical Officer & VP $373K -$36.9K -8.99% Jan 4, 2024
Christopher Dinsmore Chief Scientific Officer $309K -$21.8K -6.6% Jan 4, 2024
Charles Y. Lin Sr Vp, Research & Development $247K -$12.7K -4.88% Feb 21, 2024
Allison Frisbee Sr Vp, Corp Operations & Legal $216K -$12.8K -5.59% Feb 21, 2024
Elizabeth A. Olek Sr Vp, Clinical Science $204K -$7.77K -3.67% Feb 21, 2024
Deborah Knobelman Chief Financial Officer $173K Jun 3, 2024
Elena Ridloff Director $31.4K Jun 25, 2024
Roshawn A. Blunt Director Jun 25, 2024
Arie Belldegrun Director Jun 25, 2024
Joshua A. Kazam Director Jun 25, 2024
Otello Stampacchia Director Jun 22, 2022
Taiyin Yang Director Jun 25, 2024
Sandra A. Gardiner Interim CFO Sep 15, 2023
Katherine V. Stultz Director Jun 25, 2024
David M. Tanen Director Jun 25, 2024
Marianne De Backer Director Jun 22, 2023
Roger D. Dansey Director Jun 25, 2024

Recent Insider Transactions by Companies or Individuals for Kronos Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.